The abstract is read at the publisher; the summary is JClub's.
A recurrent CAPN3 3'UTR variant, c.*534T>C, is linked to persistent hyperCKemia with markedly reduced calpain-3 expression in 13 individuals from 11 families.
- Why it matters: Many suspected neuromuscular genetic cases remain undiagnosed, and non-coding 3'UTR variants may be a hidden source of pathogenicity that is often hard to interpret.
- What they did: The study combined clinical workup with muscle biopsy/MRI, in silico predictions of miRNA/RBP effects, and luciferase reporter assays testing c.*534T>C with or without RBFOX1 co-expression.
- The result: Western blot and muscle RNAseq showed absent or reduced calpain-3 and CAPN3 levels, while assays supported a regulatory effect via a new RBFOX1 binding site, making such variants therapeutically actionable.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.